US equities |
SPCX $166.72 ▲+4.88% NVDA $236.66 ▲+1.16% MU $1,064.12 ▼-1.00% TSLA $377.74 ▲+1.93% MSFT $525.55 ▲+1.55% SNDK $1,711.50 ▼-0.49% INTC $117.13 ▼-1.84% META $745.88 ▲+2.45%
FinancialContent

West Pharmaceutical Services, Inc. Common Stock (NY:WST)

372.02 +7.04 (+1.93%)
Delayed Quote Updated: 11:44 AM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about West Pharmaceutical Services, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
News headline image
3 Reasons to Sell WST and 1 Stock to Buy Instead
West Pharmaceutical Services has been treading water for the past six months, recording a small loss of 2.7% while holding steady at $248.28. The stock also ... 
Via StockStory
News headline image
1 S&P 500 Stock on Our Watchlist and 2 We Find Risky
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch... 
Via StockStory
Topics Economy Stocks
News headline image
3 Mid-Cap Stocks with Warning Signs
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with... 
Via StockStory
Topics Economy
News headline image
1 of Wall Street’s Favorite Stock with Impressive Fundamentals and 2 Facing Headwinds
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
Topics Economy
West Pharmaceutical Services (NYSE:WST) Beats Q4 Earnings Estimates, Shares Surge ↗
Via Chartmill
Which S&P500 stocks are gapping on Friday? ↗
Via Chartmill
News headline image
5 Insightful Analyst Questions From West Pharmaceutical Services’s Q4 Earnings Call
West Pharmaceutical Services’ fourth quarter results reflected robust demand for its high-value product components, particularly those tied to biologics and GLP-1 therapies. Management highlighted that... 
Via StockStory
Topics Earnings
News headline image
West Pharma (WST) Q4 2025 Earnings Call Transcript ↗
West Pharma (WST) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Get insights into the top movers in the S&P500 index of Thursday's pre-market session. ↗
Via Chartmill
News headline image
West Pharmaceutical Services’s (NYSE:WST) Q4 CY2025: Beats On Revenue, Stock Soars
Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.5% year on year to $805 million. The company... 
Via StockStory
Topics Economy
News headline image
West Pharmaceutical Services Earnings: What To Look For From WST
Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting earnings this Thursday before market hours. Here’s what to look for. 
Via StockStory
Topics Economy World Trade
News headline image
3 Cash-Producing Stocks with Open Questions
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities. 
Via StockStory
Topics Economy
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
Which S&P500 stocks are moving on Friday? ↗
Via Chartmill
Curious about which S&P500 stocks are generating unusual volume on Wednesday? Find out below. ↗
Via Chartmill
News headline image
THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point
ISSUED ON BEHALF OF DOSEOLOGY SCIENCES INC. 
From USA News Group
Via GlobeNewswire
Exploring the top movers within the S&P500 index during today's session. ↗
Via Chartmill
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
1 Mid-Cap Stock on Our Watchlist and 2 That Underwhelm
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
Topics Economy
News headline image
2 Safe-and-Steady Stocks with Solid Fundamentals and 1 We Question
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
Topics Economy
News headline image
The Biotech Revolution’s Ultimate ‘Picks and Shovels’ Play: A Deep Dive into West Pharmaceutical Services (WST)
As the pharmaceutical industry undergoes its most significant transformation in decades, the spotlight often falls on the blockbuster drugs themselves—the weight-loss miracles and the life-saving... 
Via MarketMinute
Topics Economy
News headline image
Picks and Shovels of the Biotech Revolution: A Deep Dive into West Pharmaceutical Services (WST)
Date: December 23, 2025 Introduction In the high-stakes world of biotechnology and pharmaceutical manufacturing, few companies are as indispensable yet as quietly influential as West Pharmaceutical... 
Via PredictStreet
Topics Economy Intellectual Property Supply Chain
News headline image
1 S&P 500 Stock Worth Your Attention and 2 We Avoid
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Economy Stocks
News headline image
3 Profitable Stocks We Approach with Caution
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
Topics Economy
News headline image
Monday's session: top gainers and losers in the S&P500 index ↗
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
News headline image
3 Reasons WST is Risky and 1 Stock to Buy Instead
West Pharmaceutical Services’s 34.6% return over the past six months has outpaced the S&P 500 by 20.2%, and its stock price has climbed to $284.57 per share. This was partly thanks to its solid... 
Via StockStory
Topics Stocks
News headline image
1 Healthcare Stock with Promising Prospects and 2 We Question
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized strong financial performance, and over the past... 
Via StockStory
Topics Economy Stocks
News headline image
Option Care Health, DaVita, Revvity, West Pharmaceutical Services, and Bausch + Lomb Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
Via StockStory
Topics Economy
News headline image
Looking Into West Pharmaceutical Services Inc's Recent Short Interest ↗
 
Via Benzinga
News headline image
Winners And Losers Of Q3: West Pharmaceutical Services (NYSE:WST) Vs The Rest Of The Drug Development Inputs & Services Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at drug development inputs & services stocks,... 
Via StockStory
Topics Economy
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >